Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
The great people I work with.
Was sind einige der besten Dinge an Ihrem Team?
Most friendly welcoming team that I have worked with!
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Such a warm welcoming environment!
Was gefällt dir am besten am Führungsteam?
Very teamwork oriented. The team strives to accomplish goals and milestones to better the company.
Other Employee Reviews for Karyopharm Therapeutics
×